Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein

Journal of Virology

Volumn 76, Issue 21, 2002, Pages 11054-11064

  Peters, Gregory A ^a   Khoo, David ^a   Mohr, Ian ^a   Sen, Ganes C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACT PROTEIN; PROTEIN PKR; PROTEIN SERINE THREONINE KINASE; PROTEIN US11; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GENE MUTATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION;

APOPTOSIS; EIF-2 KINASE; ENZYME ACTIVATION; HERPESVIRUS 1, HUMAN; HUMANS; RNA-BINDING PROTEINS; TUMOR CELLS, CULTURED; VIRAL PROTEINS;

EID: 0036839211     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.21.11054-11064.2002     Document Type: Article

References (46)

1. Benkirane, M., C. Neuveut, R. F. Chun, S. M. Smith, C. E. Samuel, A. Gatignol, and K. T. Jeang. 1997. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16:611-624.
2. Bischoff, J. R., and C. E. Samuel. 1985. Mechanism of interferon action. The interferon-induced phosphoprotein PI possesses a double-stranded RNA-dependent ATP-binding site. J. Biol. Chem., 260:8237-8239.
3. Carpick, B. W., V. Graziano, D. Schneider, R. K. Maitra, X. Lee, and B. R. G. Williams. 1997. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-aaactivating region RNA. J. Biol. Chem. 272:9510-9516.
4. y134.5 gene if present before the activation of protein kinase R by precluding its phosphorylation and that of the α subunit of eukaryotic translation initiation factor 2. J. Virol. 72:8620-8626.
5. Cassady, K. A., and M. Gross. 2002. The herpes simplex virus type 1 Us11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J. Virol. 76:2029-2035.
6. Chang, H. W., J. C. Watson, and B. L. Jacobs. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 89:4825-4829.
7. y134.5, a gene non-essential for growth in culture. Science 250:1262-1266.
8. y134.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89:3266-3270.
9. y134.5 mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 92:10516-10520.
10. Chu, W. M., D. Ostertag, Z. W. Li, L. Chang, Y. Chen, Y. Hu, B. Williams, J. Perrault, and M. Karin. 1999. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11:721-731.
11. Clarke, P. A., M. Schwemmle, J. Schickinger, K. Hilse, and M. J. Clemens. 1991. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19:243-248.
12. Clemens, M. J., and A. Elia. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:503-524.
13. Cosentino, G. P., S. Venkatesan, F. C. Serluca, S. R. Green, M. B. Mathews, and N. Sonenberg. 1995. Doubte-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA 92:9445-9449.
14. Cuddihy, A. R., A. H. Wong, N. W. Tam, S. Li, and A. E. Koromilas. 1999. The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18:2690-2702.
15. D'Acquisto, F., and S. Ghosh. 2001. PACT and PKR: turning on NF-κB in the absence of virus. Sci. STKE 89:1-4.
16. Davies, M. V., H. W. Chang, B. L. Jacobs, and R. J. Kaufman. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67:1688-1692.
17. Green, S. R., and M. B. Mathews. 1992. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6:2478-2490.
18. Gunnery, S., A. P. Rice, H. D. Robertson, and M. B. Mathews. 1990. Tatresponsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87:8687-8691.
19. y134.5 protein of herpes simplex virus complexes with protein phosphatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by the double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 94:843-848.
20. Imani, F., and B. L. Jacobs. 1988. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype I σ3 protein. Proc. Natl. Acad. Sci. USA 85:7887-7891.
21. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol. 20:617-627.
22. Ito, T., M. Yang, and W. S. May. 1999. RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274:15427-15432.
23. Kawagishi-Kobayashi, M., J. B. Silverman, T. L. Ung, and T. E. Dever. 1997. Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2α. Mol. Cell. Biol. 17:4146-4158.
24. Kumar, A., J. Haque, J. Lacoste, J. Hiscott, and B. R. Williams. 1994. Double-stranded RNA-dependent protein kinase activates transcription factor NF-KB by phosphorylating IκB. Proc. Natl. Acad. Sci. USA 91:6288-6292.
25. Kumar, A., Y. L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B. R. Williams. 1997. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16:406-416.
26. r 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87:6208-6212.
27. Maclean, C. A., F. J. Rixon, and H. S. Marsden. 1987. The products of gene Us11 of herpes simplex virus type I are DNA-binding and localize to the nucleoli of infected cells. J. Gen. Virol. 43:1921-1937.
28. Mohr, I., and Y. Gluzman. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15:4759-4766.
29. Mulvey, M., J. Poppers, A. Ladd, and I. Mohr. 1999. A herpesvirus ribosome associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function. J. Virol. 73:3375-3385.
30. Nanduri, S., B. W. Carpick, Y. Yang, B. R. Williams, and J. Qin. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17:5458-5465.
31. Patel, C. V., I. Handy, T. Goldsmith, and R. C. Patel. 2000. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase PKR. J. Biol. Chem. 275:37993-37998.
32. Patel, R. C., and G. C. Sen. 1992. Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267:7671-7676.
33. Patel, R. C., and G. C. Sen. 1998. PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17:4379-4390.
34. Patel, R. C., P. Stanton, N. M. McMillan, B. R. Williams, and G. C. Sen. 1995. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92:8283-8287.
35. Patel, R. C., P. Stanton, and G. C. Sen. 1996. Specific mutations near the amino terminus of double-stranded RNA-dependent protein kinase (PKR) differentially affect its double-stranded RNA binding and dimerization properties. J. Biol. Chem. 271:25657-25663.
36. Peters, G. A., R. Hartmann, J. Qin, and G. C. Sen. 2001. Modular structure of PACT: distinct domains for binding and activating PKR. Mol. Cell. Biol. 21:1908-1920.
37. Peters, G. A., J. Poppers, 1. Mohr, and G. C. Sen. 2001. PACT-mediated PKR activation is blocked by HSV-1 Us11 protein. J. Interferon Cytokine Res. 21(Suppl. 1):SI29
38. Poppers, J., M. Mulvey, D. Khoo, and 1. Mohr. 2000. Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J. Virol. 74:11215-11221.
39. Roller, R. J., and B. Roizman. 1992. The herpes simplex virus I RNA binding protein Us11 is a virion component and associates with ribosomal 60S subunits. J. Virol. 66:3624-3632.
40. Roller, R. J., L. L. Monk, D. Stuart, and B. Roizman. 1996. Structure and function in the herpes simplex virus I RNA-binding protein Us11: mapping of the domain required for ribosomal and nucleolar association and RNA binding in vitro. J. Virol. 70:2842-2851.
41. Romano, P. R., M. T. Garcia-Barrio, X. Zhang, Q. Wang, D. R. Taylor, F. Zhang, C. Herring, M. B. Mathews, J. Qin, and A. G. Hinnebusch. 1998. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2α kinases PKR and GCN2. Mol. Cell. Biol. 18:2282-2297.
42. Sen, G. C. 2001. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
43. Williams, B. R. 1999. PKR, a sentinel kinase for cellular stress. Oncogene 18:6112-6120.
44. Wong, A. H., N. W. Tam, Y. L. Yang, A. R. Cuddihy, S. Li, S. Kirchhoff, H. Hauser, T. Decker, and A. E. Koromilas. 1997. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16:1291-1304.
45. Yasukawa, T., C. Kanei-Ishii, T. Maekawa, J. Fujimoto, T. Yamamoto, and S. Ishii. 1995. Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxin. J. Biol. Chem. 270:25328-25331.
46. Zamanian-Daryoush, M, T. H. Mogensen, J. A. DiDonato, and B. R. Williams. 2000. NF-KB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-κB-inducing kinase and IκB kinase. Mol. Cell. Biol. 20:1278-1290.